Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID)
The consortium seeks to classify what kinds of neurological symptoms and conditions occurred in patients infected with SARS-CoV-2 and to determine their prevalence.
The consortium seeks to classify what kinds of neurological symptoms and conditions occurred in patients infected with SARS-CoV-2 and to determine their prevalence.
One-third or more of adults with COVID-19 showed neurological manifestations on presentation and/or during hospital admission, with many experiencing post-discharge adverse cognitive and emotional health outcomes.
The S. William Stezoski Award is an annual award presented to the top technician at the Center, as voted by the Safar Center Associate Directors.
Henry Alexander was selected unanimously by the Associate Directors of the Center to be the inaugural recipient of the S. William Stezoski Award for Technician Excellence.
Hülya Bayır, MD received U01 funding from the National Institute of Allergy and Infectious Diseases to combat multi-system effects of ionizing radiation.
Medical Scientist Training Program student Andrew Lamade, PhD successfully defended his thesis.